Shanghai aStem Biomedical Technology

Shanghai aStem Biomedical Technology is a biotechnology company specializing in the development of induced pluripotent stem cell (iPSC) derived therapies. The company leverages its proprietary platform to differentiate iPSCs into high-purity functional cells, including cardiomyocytes and neural cells, for the treatment of degenerative diseases. Their primary focus is on cardiovascular repair, specifically targeting heart failure through the transplantation of iPSC-derived cardiomyocytes. aStem also explores applications in neurology and ophthalmology, aiming to provide off-the-shelf regenerative medicine solutions. By addressing the challenges of large-scale production and cell purity, the company seeks to advance the clinical application of regenerative medicine.